Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

Thymosin β4 helps with healing, inflammation, and organ protection.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Finasteride treatment makes the prostate look more like a healthy one.

Caffeine may help reduce stress-induced hair loss.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Cromakalim relaxes various blood vessels, while minoxidil sulphate is more selective; they likely act on different potassium channels.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

Androgen receptors help prostate cancer cells grow and resist drugs.

The study developed methods to measure biomarkers in mice and found differences in hormone levels linked to gut microbiota diversity and stress response.

Angiogenin helps hair grow by stimulating cell growth and blood vessel formation.

Higher androgen receptor levels in bald areas may cause hair loss, while estrogen receptors have less impact.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

Sphingosine 1-phosphate affects inflammation and gene expression in different aorta cells.

The inhibitor affects androgen metabolism but not ovarian function.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Clinical signs and blood tests are not very helpful in diagnosing hyperadrenocorticism in dogs.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Minoxidil can reduce functions related to androgen receptors.